ARQ National Psychotrauma Centre

With its open access character, the European Journal of Psychotraumatology aims to promote evidence-based treatments around the world, while at the same time welcoming new forms of treatment without losing its critical scientific eye. Eye movement desensitization and reprocessing therapy (EMDR) is by now a well-established treatment for posttraumatic stress disorder (PTSD).

Existing tools for evaluating psychosocial interventions (un-validated self-reporting questionnaires) are not ideal for use in non-Western conflict settings. We implement a generic method of treatment evaluation, using client and counsellor feedback, in 18 projects in non-Western humanitarian settings. We discuss our findings from the perspective of validity and suggestions for future research. A retrospective analysis is executed using data gathered from psychosocial projects.

Five years ago, the European Society for Traumatic Stress Studies (ESTSS) launched European Journal of Psychotraumatology (EJPT) (Olff, 2010). Knowing very little about the world of publishing and in particular about Open Access, it was quite an adventure! Somewhat idealistic, and after having been convinced that Open Access is the future publishing model, we performed a detailed search among potential publishers and found Co-Action Publishing, a relatively small Swedish publisher but with a great deal of experience in journals publishing and with a passion for Open Access.

Background: Prolonged grief disorder (PGD) is a potentially disabling condition affecting approximately 10% of bereaved people. It has been suggested that the impaired integration of the loss memory, as expressed in recurrent memories of the loss and disorganization of memory, is involved in the development of PGD.

A number of evidence-based psychotherapeutic approaches for the treatment of posttraumatic stress disorder (PTSD) are available. They differ in various ways, however, they also have a number of commonalities. Given this situation, clinicians may wonder which treatment program to use, or more specifically, which treatment components are critical for a successful therapy.

Background
Deployment can put soldiers at risk of developing post-traumatic stress symptoms. Despite several longitudinal studies, little is known about the timing of an increase in post-traumatic stress symptoms relative to pre-deployment. Longitudinal studies starting pre-deployment, in which participants are repeatedly measured over time, are warranted to assess the timing of an increase in symptoms to ultimately assess the timing of an increase in treatment demand after deployment.
Methods

Genomic variation in the SKA2 gene has recently been identified as a promising suicide biomarker. In light of its role in glucocorticoid receptor transactivation, we investigated whether SKA2 DNA methylation influences cortisol stress reactivity and is involved in the development of post-traumatic stress disorder (PTSD). Increased SKA2 methylation was significantly associated with lower cortisol stress reactivity in 85 healthy individuals exposed to the Trier Social Stress Test (B=−173.40, t=−2.324, p-value=0.023).

Background
Consequences of war-related traumatisation have mostly been investigated in military and predominant male populations, while research on female civilian victims of war has been neglected. Furthermore, research of post-war posttraumatic stress disorder (PTSD) in women has rarely included early-life trauma in their prediction models, so the contribution of trauma in childhood and early youth is still unexplored.
Objective

This Special Communication argues against changing the definition of posttraumatic stress disorder in DSM-5.Are changes to the definition of posttraumatic stress disorder in DSM-5 a step forward? -No. The purpose of revising a psychiatric definition is to enhance diagnostic accuracy, clinical utility, and communication. The DSM-5 definition of PTSD provides no improvement in these areas. This